FIELD: biotechnology.
SUBSTANCE: invention relates to the production of engineered T-cells, as well as to the stimulation of T-cells. At the same time, the stages of production and stimulation include incubation of the initial composition under stimulating conditions for 2–6 days, as well as the introduction of a nucleic acid encoding a genetically engineered recombinant receptor into a population of T-cells.
EFFECT: invention is effective for stimulation of T-cells.
79 cl, 3 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS FOR PRODUCTION OF COMPOSITIONS OF GENETICALLY ENGINEERED CELLS AND RELATED COMPOSITIONS | 2018 |
|
RU2790444C2 |
| CHIMERIC RECEPTORS CONTAINING TRAF-6-INDUCING DOMAINS AND COMPOSITIONS AND METHODS RELATED TO THEM | 2016 |
|
RU2773159C2 |
| REAGENTS FOR REPRODUCTION OF CELLS EXPRESSING RECOMBINANT RECEPTORS | 2018 |
|
RU2783956C2 |
| COMBINATION OF CELL THERAPY AND IMMUNOMODULATOR COMPOUND | 2018 |
|
RU2777911C2 |
| NEW CHIMERIC ANTIGEN RECEPTOR CONSTRUCTS CONTAINING TNFR2 DOMAINS | 2019 |
|
RU2808254C2 |
| CHIMERIC ANTIBODY/T-CELL RECEPTOR STRUCTURES AND THEIR APPLICATIONS | 2016 |
|
RU2767209C2 |
| ANTI-IDIOTYPIC ANTIBODIES AND METHODS RELATED TO THEM | 2017 |
|
RU2773355C2 |
| PRODUCTION OF CONSTRUCTED CELLS FOR ADOPTIVE CELL THERAPY | 2017 |
|
RU2780156C2 |
| METHODS FOR MODULATING CART-CELLS | 2017 |
|
RU2774232C2 |
| METHODS FOR PRODUCING CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTOR | 2015 |
|
RU2751362C2 |
